Pharma BP develops localised market access strategies considering the differing access drivers across regional and country level institutions
Pharma and biotech companies must have an effective market access strategy to ensure access for the widest possible patient group, at prices in line with global strategic goals. Strategies for markets with universal coverage vs. a strong out of pocket market will vary, and getting the right strategy in place for the right market is key.
Our engagements are customised per client situation and typically involve an assessment of the competitive landscape, product value drivers, the regulatory landscape and pricing potential alongside the provision of a clear and actionable access strategy. Our methodologies include:
